Red One Medical and Prytime Medical Devices Announce Exclusive Partnership

Red One Medical, a proven government contractor providing best-in-class medical supplies to Veterans Affairs and the Department of Defense, is proud to exclusively partner with Prytime Medical Devices, Inc. (The REBOA Company™), a privately held medical technology company focused on minimally invasive solutions for trauma.

As a Service Disabled Veteran Owned Small Business (SDVOSB), Red One Medical specializes in serving the US military’s needs in Operational Medicine, Military Treatment Facilities and the VA.

Prytime Medical’s newly refined flagship product, the ER-REBOA™ PLUS Catheter, provides clinicians  an effective tool to control bleeding and stabilize patients in hemorrhagic shock, utilizing a minimally invasive technique called REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta). The catheter was designed specifically for emergency and critical care environments, making it a perfect match for combat medicine.

“Our flagship technology and technique arose from military medicine in the field, and now we’re bringing the lessons learned from war to civilian trauma back home,” said Prytime Medical’s CEO David Spencer. “Our partnership with veteran-owned Red One Medical supports our original mission to support combat wounded military members and those who treat them.”

“We’re proud to get these cutting-edge medical devices into the hands of US military trauma surgeons and other medical providers close to the point of injury,” said Red One Medical’s CEO Charles Pollak. “Red One works hard to bridge the gap between private sector innovations and government contracting, because we know these devices can save lives.”

The new PLUS design improves on the original ER-REBOA™ by adding five new features to help control massive non-compressible hemorrhage, including:
1) “Landing zone” markers to easily identify zones 1 and 3
2) Repackaged peel away sheath  to reduce prep time
3) Length markers on both sides of catheter for better visibility
4) Documentation tag to capture critical information
5) Guidewire compatible  for subsequent vascular procedures

Prytime Medical also offers the ER-REBOA™ PLUS Training Catheter and ARTI Simulator for arterial access training.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.